GI
GSK icon

GAMCO Investors’s GSK GSK Stock Holding History

GAMCO Investors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,117
Closed -$215K – 885
2022
Q4 		$215K Sell
6,117
-1,078
-15% -$35.9K ﹤0.01% 823
2022
Q3 		$212K Sell
7,195
-186
-3% -$7.05K ﹤0.01% 819
2022
Q2 		$402K Sell
7,381
-3,116
-30% -$172K ﹤0.01% 724
2022
Q1 		$572K Sell
10,497
-2,093
-17% -$114K 0.01% 709
2021
Q4 		$694K Sell
12,590
-8,718
-41% -$454K 0.01% 687
2021
Q3 		$1.02M Buy
21,308
+3,858
+22% +$194K 0.01% 624
2021
Q2 		$869K Sell
17,450
-99
-0.6% -$4.76K 0.01% 672
2021
Q1 		$783K Sell
17,549
-2,399
-12% -$109K 0.01% 676
2020
Q4 		$918K Sell
19,948
-9,122
-31% -$419K 0.01% 623
2020
Q3 		$1.37M Sell
29,070
-2,706
-9% -$136K 0.02% 523
2020
Q2 		$1.62M Buy
31,776
+3,702
+13% +$190K 0.02% 491
2020
Q1 		$1.33M Buy
28,074
+42
+0.1% +$2.24K 0.02% 502
2019
Q4 		$1.65M Sell
28,032
-5,920
-17% -$329K 0.01% 532
2019
Q3 		$1.81M Buy
33,952
+1,360
+4% +$70K 0.02% 511
2019
Q2 		$1.63M Sell
32,592
-3,552
-10% -$178K 0.01% 529
2019
Q1 		$1.89M Buy
+36,144
New +$1.81M 0.01% 491

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GAMCO Investors's GSK Position: Q1 2023 in Review

GAMCO Investors sold out of GSK (GSK) in Q1 2023, closing a stake of 6,117 shares — an estimated $215K sold.

GAMCO Investors first reported a position in GSK in Q1 2019 and held it in 16 quarters. The position peaked at $1.89M in Q1 2019. 809 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

  • GAMCO Investors reported no remaining GSK position as of Q1 2023 after selling out during the quarter.
  • GAMCO Investors sold 6,117 GSK shares in Q1 2023, an estimated $215K.
  • GAMCO Investors first reported a position in GSK in Q1 2019 and held it in 16 quarters.
  • GAMCO Investors's GSK position peaked at $1.89M in Q1 2019.
  • 809 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on GAMCO Investors's 13F filing for Q1 2023, filed 12 May 2023.